New Ray Medicine International Holding Ltd. (HK:6108) has released an update.
New Ray Medicine International Holding Ltd. reported a significant decrease in revenue for the first half of 2024, with a 46.1% drop compared to the same period in 2023, along with a reduction in net loss by 69.4%. The company, which did not declare an interim dividend, also showed a substantial comprehensive expense for the period, reflecting continued financial challenges.
For further insights into HK:6108 stock, check out TipRanks’ Stock Analysis page.